Fig. 7From: The landscape of Mucopolysaccharidosis in Southern and Eastern European countries: a survey from 19 specialistic centersCardiac function parameters considered appropriate to demonstrate the clinical benefit of ERT in patients with MPS IVA (% of respondents)Back to article page